During the past decade, Clinica de Investigacion en Reumatologia y Obesidad conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinica de Investigacion en Reumatologia y Obesidad" are "Arthritis, Rheumatoid" (1 trials), "Autoimmune Disorder" (1 trials), "Primary Sjögren's Syndrome" (1 trials), "Rheumatoid Arthritis" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Clinica de Investigacion en Reumatologia y Obesidad" in a lesser frequency.

Most popular intervention types in "Clinica de Investigacion en Reumatologia y Obesidad" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Acthar Gel" (1 trials), "Placebo" (1 trials), "abatacept" (1 trials), "branebrutinib" (1 trials) and "branebrutinib placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica de Investigacion en Reumatologia y Obesidad" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Clinica de Investigacion en Reumatologia y Obesidad". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Clinica de Investigacion en Reumatologia y Obesidad, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinica de Investigacion en Reumatologia y Obesidad, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".